STOCK TITAN

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: LFWD) to release fourth quarter and fiscal year-end 2023 financial results on February 27, 2024. Conference call with CEO and CFO to discuss financial results. Webcast available on GoLifeward.com.
Positive
  • None.
Negative
  • None.

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability, today announced that the Company will release its fourth quarter and fiscal year-end 2023 financial results before the markets open on Tuesday, February 27, 2024.

Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EST to discuss the financial results. To access the call, analysts and investors may utilize the following:

Toll free (U.S.)1-833-316-0561
International (U.S)1-412-317-0690
Germany069-22221534
Israel1-80-9212373
Access CodePlease reference the “Lifeward Earnings Call”


The conference call will be webcast live and the webcast can be accessed through a link on the Company’s website at GoLifeward.com in the "Investors" section, or through the following link: https://edge.media-server.com/mmc/p/3pun37to/. An archived webcast will also be available on the company's website.

About Lifeward

Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity systems, the ReStore Exo-Suit, and the MyoCycle FES Systems.

Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward mission and product portfolio, please visit GoLifeward.com.

ReWalk®, ReStore® and Alter G® are registered trademarks of ReWalk Robotics Ltd. (DBA Lifeward) and/or its affiliates.

Lifeward Media Relations:
LifeSci Communications
E: media@golifeward.com

Lifeward Investor Contact:
Mike Lawless
Chief Financial Officer
Lifeward
E: ir@golifeward.com


FAQ

When will ReWalk Robotics Ltd. release its fourth quarter and fiscal year-end 2023 financial results?

ReWalk Robotics Ltd. will release its fourth quarter and fiscal year-end 2023 financial results before the markets open on Tuesday, February 27, 2024.

Who will host the conference call to discuss the financial results?

Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host the conference call to discuss the financial results.

How can analysts and investors access the conference call?

Analysts and investors can access the conference call by dialing Toll free (U.S.) 1-833-316-0561, International (U.S.) 1-412-317-0690, Germany 069-22221534, or Israel 1-80-9212373. They can also access the webcast through a link on the Company’s website at GoLifeward.com.

Where can the webcast of the conference call be accessed?

The webcast of the conference call can be accessed through a link on the Company’s website at GoLifeward.com in the 'Investors' section or through the following link: https://edge.media-server.com/mmc/p/3pun37to/.

Will there be an archived webcast available?

Yes, an archived webcast will also be available on the company's website.

ReWalk Robotics Ltd.

NASDAQ:RWLK

RWLK Rankings

RWLK Latest News

RWLK Stock Data

8.92M
58.82M
1.96%
20.72%
2.27%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Israel
P O Box 161

About RWLK

exoskeleton leader rewalk robotics, inc. (formerly argo medical technologies) develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury (sci). rewalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. founded in 2001, rewalk has headquarters in the us, israel and germany. rewalk robotics' rewalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury (sci) to stand upright and walk. rewalk is the only exoskeleton with fda clearance via clinical studies and extensive performance testing for personal use rewalk has been tested extensively in the u.s., europe, and israel. the rewalk system is supported by the most published data of all exoskeleton systems in the rehabilitation market, and is used by more people worldwide than all other exoskeleton systems combined. the company offers two products: rewalk personal and the